•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks
Analysts’ Top Healthcare Picks: Phreesia (PHR), Xeris Pharmaceuticals (XERS)
Phreesia Inc (PHR) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth and Return to Profitability
Q1 2025 Phreesia Inc Earnings Call Transcript
Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Phreesia Inc (PHR) Q1 FY2025 Earnings: Revenue Beats Estimates, Net Loss Narrows Significantly
Phreesia GAAP EPS of -$0.35 beats by $0.15, revenue of $101.2M beats by $0.21M
Phreesia Q1 2025 Earnings Preview
Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner
Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics
Phreesia's Amy Patel Named One of PM360's 2024 ELITE 100
Phreesia Named as One of Modern Healthcare's “Best Places to Work in Healthcare” for the Eighth Time
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.